Group items tagged

Today, medical marijuana advocates in the state of Ohio took the first step towards the legalization of the use of pot for medical purposes.

Medical device stocks are somewhat insulated from the volatility of the economy on a long-term basis. A combination of recent weakness has led to attractive valuations.

The September results of integrated technology outfit General Cannabis indicate that medical marijuana may be a worthy option for recessionary investing. Profits are up three fold from the year-ago period.

Medicinal marijuana has been steadily gaining acceptance since 1996 when the state of California legalized it for medical use. Since then, more and more states have begun to allow cannabis recommendations. Today, there are 16...

As the first new Lupus drug to debut in the last half-of-a-century, Benlysta has the potential to be something special. Reception of the drug from doctors has been lukewarm thus far, but with many other treatments associated with severe potential side effects, Benlysta may be a blockbuster nonetheless.

General Cannabis licensing agreement with SC Labs has already caught the attention of several dispensaries looking to offer potency results for their strains.